PPD is Supporting Complex EU DCTs

Overview


PPD-is-Supporting-Complex-EU-DCTs.jpg

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach including: PPD RegView (a detailed regulatory “heatmap” and extensive database providing DCT-relevant information), specialized teams for each EU country which include country heads & feasibility, start-up groups, and clinical teams, establishing a process that supports principal investigator (PI) preferences, and DCT strategy development that focuses on site burden, and patient and data journeys.

This content is provided by PPD - Decentralized Clinical Trials , and any views and opinions expressed do not necessarily reflect those of Outsourcing-Pharma.com

Download Now


Related Resources

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

Content provided by PPD - Decentralized Clinical Trials

White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are becoming more widely adopted.

Helping Trial Sites Overcome Prevailing DCT Challenges

Helping Trial Sites Overcome Prevailing DCT Challenges

Content provided by PPD - Decentralized Clinical Trials

White Paper

As a CRO, PPD (part of Thermo Fisher) can help guide the future of clinical research. Its depth of experience with decentralized clinical trials (DCTs) — all over the world and of many design types — enables PPD to provide insight and feedback-based...

Supplier Info Centre

PPD-Decentralized-Clinical-Trials.jpg

For more product information visit PPD - Decentralized Clinical Trials .